News
Here you will find our latest papers, announcements and media appearances.
Latest news (2024):
We just received a notice of allowance from the United States Patent Office for the invention: “Biopsy/Cytology device for sampling cells or tissue in mammals”.
In practice this means a patent for our Loop Brush has just been allowed in the United States. We’re one step closer to diagnosing all cysts and providing a higher chance of treatment to patients with pancreatic cancer!
ReThink Capital becomes the first investor for Lucky Loop Medical
We are happy to share that ReThink Capital will be lead investor for our funding round! “Lucky Loop Medical has paved the way for groundbreaking innovation in cancer diagnostics, particularly concerning pancreatic cancer. Their revolutionary approach enables the detection of this serious illness at an earlier stage with an accuracy that surpasses current standards.” With this investment, we are building our product for the European and American market, improving the early diagnosis of pancreatic cancer!
Lucky Loop Medical supported by Cenova
Cenova is proud to support Lucky Loop Medical in realizing their vision of a novel sampling tool for harvesting cells from inside pancreatic cysts. At Cenova, we help develop tooling for, and manufacture the first prototype examples of the brush in a ISO Class 7, clean room environment. Using our long experience in component plastic manufacturing, assembly, and packaging, all in compliance with ISO 13485 and FDA 21CFR820, we can support Lucky Loop Medical in every step of the way.
Earlier diagnosis of cancer with Lucky Loop
If you have a cyst, you want the doctor to be able to tell you how severe it is. But until now, this has been more complex than it sounds. The new start-up Lucky Loop will help diagnose pancreatic cancer earlier.
KTH EECS News 2023
Brush that loosens cells in cysts could become weapon against pancreatic cancer
In a potential step forward for early pancreatic cancer diagnosis, a miniaturised brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts. If proven safe to use, the technique could dramatically increase the number of cystic cells available for analysis, a key advance given the scarcity of cells in cystic fluid drawn with a needle alone.
KTH News 2021